Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material.
Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992.
For patients, we provide the latest patient information leaflets and training materials as well as the technical information for Berlin-Chemie products available in Germany via our Medical Hub.
Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.
Discover More about Global Responsibility
From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet
Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice.
Discover More about Global Partnering
Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.
Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.
Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.
Menarini Blog
Follow Us
We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.
Our Job Portal
Find out about our current vacancies at Berlin-Chemie directly on our career portal.
2016 - 05 - 24
Menarini acquires a facility which represents Italian excellence in the sector of pharmaceutical active ingredients
PRESS RELEASE
An agreement for the sale to Menarini of the Casaletto Lodigiano facility owned by Euticals, a leader in the production of pharmaceutical active ingredients, was signed today.
Closure of the production site near Lodi has been avoided and a future has been guaranteed for the workers: an investment of 10 million euro is planned for the development and relaunch of the facility, which represents Italian excellence in fine chemicals. It will be complementary to the Menarini plants of Pisa and Lomagna, and will serve to produce high-quality active ingredients destined for strategic products.
Menarini acquires a facility which represents Italian excellence in the sector of pharmaceutical active ingredients
Florence, 23 May 2016 – Menarini continues to believe and invest in Italia and just two months after the creation of VaxYnethic, a joint venture with BiosYnth, an Italian company that is a pioneer in the field of biopharmaceutical production, today it has signed an agreement for the acquisition of the Lodichem (formerly Euticals) facility in Casaletto Lodigiano, a small Italian “jewel” in the production of pharmaceutical active ingredients. The plant, capable of producing active and intermediate ingredients, will work in synergy alongside the other Menarini chemical plants situated in Pisa and Lomagna, and will be expanded and improved thanks to an investment of 10 million euro.
The project involves the construction of a new building for offices and quality-control laboratories, as well the refurbishing of numerous systems.
"We believe strongly in this acquisition, confirming our obsessive attention to the quality of medicines. Italy has a great tradition in this sense, recognised worldwide, and at Menarini we are always proud when we manage to carry out the entire production process of a medicine in our own country. In addition, this acquisition makes it possible to save and develop a facility which otherwise was destined to close. At the same time, it represents a great opportunity for growth, with a view to promoting and relaunching examples of excellence at the regional level, recognising Italian chemistry as a strategic and leading sector for our Group" said Lucia Aleotti and Alberto Giovanni Aleotti, Chairperson and Deputy Chairperson of Menarini.